Capability Health & Human Services | |
6200 W Oakey Blvd, Las Vegas, NV 89146-1103 | |
(702) 870-7050 | |
Not Available |
Full Name | Capability Health & Human Services |
---|---|
Type | Facility |
Speciality | Clinic/center - Rehabilitation |
Location | 6200 W Oakey Blvd, Las Vegas, Nevada |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134403975 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Capability Health & Human Services 6200 W Oakey Blvd, Las Vegas, NV 89146-1103 Ph: (702) 870-7050 | Capability Health & Human Services 6200 W Oakey Blvd, Las Vegas, NV 89146-1103 Ph: (702) 870-7050 |
News Archive
PositiveID Corporation, in conjunction with its development partner RECEPTORS LLC, announced today that the companies have achieved a milestone in the development of their in vivo glucose-sensing RFID microchip to detect glucose levels in the body. The companies have completed the synthesis of a new chemical building block that will serve as the anchor of their next generation of Combinatorial Artificial Receptor (CARA™) surfaces for the sensing system component of the implantable glucose sensor.
Gene Security Network, Inc (GSN) today announced that Human Reproduction published results validating the exceptional performance of GSN's proprietary Parental SupportTM technology over existing methods to detect chromosome abnormalities during in vitro-fertilization (IVF).
Pain all over, fatigue and difficulty sleeping - and no measurable answer for what could be wrong.
A new genome-wide study examines genetic variants associated with nine metabolic traits and is the first to draw out novel variants from a population unselected for current disease. The traits are indicators for common disease such as cardiovascular disease, type 2 diabetes, blood pressure, inflammation and lipid levels.
The United States Preventive Services Task Force issues new recommendations for screening for BRCA1 and BRCA2 gene mutations in the Sept. 6, 2005, issue of Annals of Internal Medicine.
› Verified 5 days ago